P2Y(12) receptor Upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain

Department of Anatomy and Neuroscience, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 04/2008; 28(11):2892-902. DOI: 10.1523/JNEUROSCI.5589-07.2008
Source: PubMed

ABSTRACT Microglia in the spinal cord may play an important role in the development and maintenance of neuropathic pain. A metabotropic ATP receptor, P2Y(12), has been shown to be expressed in spinal microglia constitutively and be involved in chemotaxis. Activation of p38 mitogen-activated protein kinase (MAPK) occurs in spinal microglia after nerve injury and may be related to the production of cytokines and other mediators, resulting in neuropathic pain. However, it remains unknown whether any type of P2Y receptor in microglia is involved in the activation of p38 MAPK and the pain behaviors after nerve injury. Using the partial sciatic nerve ligation (PSNL) model in the rat, we found that P2Y(12) mRNA and protein increased in the spinal cord and peaked at 3 d after PSNL. Double labeling studies revealed that cells expressing increased P2Y(12) mRNA and protein after nerve injury were exclusively microglia. Both pharmacological blockades by intrathecal administration of P2Y(12) antagonist and antisense knockdown of P2Y(12) expression suppressed the development of pain behaviors and the phosphorylation of p38 MAPK in spinal microglia after PSNL. The intrathecal infusion of the P2Y(12) agonist 2-(methythio) adenosine 5'-diphosphate trisodium salt into naive rats mimicked the nerve injury-induced activation of p38 in microglia and elevated pain behaviors. These data suggest a new mechanism of neuropathic pain, in which the increased P2Y(12) works as a gateway of the following events in microglia after nerve injury. Activation of this receptor by released ATP or the hydrolyzed products activate p38 MAPK pathway and may play a crucial role in the generation of neuropathic pain.

  • [Show abstract] [Hide abstract]
    ABSTRACT: P2Y receptors have been implicated in the calcium mobilization by the response to neuroexcitatory substances in neurons and astrocytes, but little is known about P2Y receptors in microglia cells. In the present study, the effects of ADP on the intracellular calcium concentration ([Ca2+]i) in cultured dorsal spinal cord microglia were detected with confocal laser scanning microscopy using fluo-4/AM as a calcium fluorescence indicator that could monitor real-time alterations of [Ca2+]i. Here we show that ADP (0.01–100 μM) causes a rapid increase in [Ca2+]i with a dose-dependent manner in cultured microglia. The action of ADP on [Ca2+]i was significantly blocked by MRS2211 (a selective P2Y13 receptor antagonist), but was unaffected by MRS2179 (a selective P2Y1 receptor antagonist) or MRS2395 (a selective P2Y12 receptor antagonist), which suggest that P2Y13 receptor may be responsible for ADP-evoked Ca2+ mobilization in cultured microglia. P2Y13-evoked Ca2+ response can be obviously inhibited by BAPTA-AM and U-73122, respectively. Moreover, removal of extracellular Ca2+ (by EGTA) also can obvious suppress the Ca2+ mobilization. These results means both intracellular calcium and extracellular calcium are potentially important mechanisms in P2Y13 receptor-evoked Ca2+ mobilization. However, P2Y13 receptor-evoked Ca2+ response was not impaired after CdCl2 and verapamil administration, which suggest that voltage-operated Ca2+ channels may be not related with P2Y13-evoked Ca2+ response. In addition, Ca2+ mobilization induced by ADP was abolished by different store-operated Ca2+ channels (SOCs) blocker, 2-APB (50 μM) and SKF-96365 (1 mM), respectively. These observations suggest that the activation of P2Y13 receptor might be involved in the effect of ADP on [Ca2+]i in cultured dorsal spinal cord microglia. Furthermore, our results raise a possibility that P2Y13 receptor activation causes Ca2+ release from Ca2+ store, which leads to the opening of SOCs.
    Neurochemical Research 09/2014; 39(11). DOI:10.1007/s11064-014-1426-8 · 2.55 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The management of the pain state is of great therapeutic relevance to virtually every medical specialty. Failure to manage its expression has deleterious consequence to the well-being of the organism. An understanding of the complex biology of the mechanisms underlying the processing of nociceptive information provides an important pathway towards development of novel and robust therapeutics. Importantly, preclinical models have been of considerable use in determining the linkage between mechanism and the associated behaviorally defined pain state. This review seeks to provide an overview of current thinking targeting pain biology, the use of preclinical models and the development of novel pain therapeutics. Issues pertinent to the strengths and weaknesses of current development strategies for analgesics are considered.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The vital role of glial cells in the nervous system has only been revealed relatively recently as these cells are electrically silent. Technical advances that allow direct visualization of glial activity have therefore been paramount to the recent glial renaissance. One such technique, two-photon laser scanning microscopy (2PLSM), forms the basis of our thesis. 2PLSM offers the necessary spatial and temporal resolution to study glial cells in intact living brain. Exploiting the strengths of 2PLSM, we chose to examine key roles of glial water and ion homeostasis in health and disease. Our first study (Paper I) delineated a novel aquaporin-4 (AQP4) mediated glial signaling pathway that is activated in response to hypo-osmotic brain edema, and which may contribute to the high mortality of this condition. In the second study (Paper II) we showed that AQP4 plays a crucial role in oxygen microdistribution during cortical spreading depression (CSD), a wave of tissue depolarization closely linked to migraine. In the next study (Paper III), we found that general anesthetics directly suppress astrocyte calcium signals, and this effect may explain some of the sedative effects of these drugs. In Paper IV we explored the paravascular circulation of cerebrospinal fluid (CSF) through brain, and found that this compartment served both as a highway for selective lipid transport and signal mediation between astrocytes. In Paper V we used 2PLSM to show a pathological activation of microglia in the advanced stages of hepatic encephalopathy (HE), which may be linked to the development of fatal brain edema in severe cases of this condition. Finally, in Paper VI we use a congenital disorder of ammonia handling to show that the immediate neurotoxicity of ammonia is mediated by a direct shortcircuiting of astrocyte potassium buffering. This secondarily causes an impairment of inhibitory neurotransmission, and is not related to astrocyte swelling as was previously hypothesized. Blocking the downstream accumulation of chloride in neurons using Na+-K+-2Cl- cotransporter subtype-1 (NKCC1) inhibitor bumetanide, we were able to reverse ammonia neurotoxicity and thus develop a clinically relevant therapy. Taken together, using in vivo 2PLSM imaging we were able to elucidate important roles of glial cells in normal brain function and debilitating neurological disorders.
    06/2013, Degree: PhD, Supervisor: Maiken Nedergaard and Erlend A. Nagelhus